WO2024191972A3 - Anti-lipocalin-2 antibodies and uses thereof - Google Patents
Anti-lipocalin-2 antibodies and uses thereof Download PDFInfo
- Publication number
- WO2024191972A3 WO2024191972A3 PCT/US2024/019489 US2024019489W WO2024191972A3 WO 2024191972 A3 WO2024191972 A3 WO 2024191972A3 US 2024019489 W US2024019489 W US 2024019489W WO 2024191972 A3 WO2024191972 A3 WO 2024191972A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antibodies
- antigen
- binding fragments
- lipocalin
- lcn2
- Prior art date
Links
- 239000000427 antigen Substances 0.000 abstract 5
- 102000036639 antigens Human genes 0.000 abstract 5
- 108091007433 antigens Proteins 0.000 abstract 5
- 239000012634 fragment Substances 0.000 abstract 5
- 102100035405 Neutrophil gelatinase-associated lipocalin Human genes 0.000 abstract 2
- 101001023833 Homo sapiens Neutrophil gelatinase-associated lipocalin Proteins 0.000 abstract 1
- 108010051335 Lipocalin-2 Proteins 0.000 abstract 1
- 239000000611 antibody drug conjugate Substances 0.000 abstract 1
- 229940049595 antibody-drug conjugate Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
This application relates to antibodies or antigen-binding fragments thereof that bind to Lipocalin-2(LCN2) protein, antibody -drug conjugates comprising such antibodies or antigen-binding fragments, as well as polynucleotides and vectors that encode for such antibodies or antigen-binding fragments. This application further relates to methods of producing the antibodies or antigen-binding fragments and using the antibodies or antigen-binding fragments for treatment of diseases.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202363451869P | 2023-03-13 | 2023-03-13 | |
US63/451,869 | 2023-03-13 | ||
US202363537089P | 2023-09-07 | 2023-09-07 | |
US63/537,089 | 2023-09-07 | ||
US202463621821P | 2024-01-17 | 2024-01-17 | |
US63/621,821 | 2024-01-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2024191972A2 WO2024191972A2 (en) | 2024-09-19 |
WO2024191972A3 true WO2024191972A3 (en) | 2024-10-31 |
Family
ID=92756351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2024/019489 WO2024191972A2 (en) | 2023-03-13 | 2024-03-12 | Anti-lipocalin-2 antibodies and uses thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024191972A2 (en) |
-
2024
- 2024-03-12 WO PCT/US2024/019489 patent/WO2024191972A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2024191972A2 (en) | 2024-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202004730B (en) | Anti-claudin 18.2 antibodies and uses thereof | |
MX2020009366A (en) | Anti-cd73 antibodies and uses thereof. | |
WO2021227307A8 (en) | Anti-cd73 antibody and use thereof | |
NO954626L (en) | Single-chain anti-EGFR Fvs and anti-EGFR antibodies | |
TW200500377A (en) | Method of humanizing immune system molecules | |
WO2022081718A8 (en) | Anti-c-c chemokine receptor 8 (ccr8) antibodies and methods of use thereof | |
MX2020008736A (en) | B7-h4 antibody formulations. | |
WO2021173896A8 (en) | Materials and methods for modulating an immune response | |
WO2019217145A8 (en) | Anti-dll3 antibodies and uses thereof | |
WO2021090062A8 (en) | Anti-mesothelin eribulin antibody-drug conjugates and methods of use | |
ZA202008095B (en) | Humanized antibodies against psma | |
MX2020009522A (en) | Anti-folate receptor 1 antibodies and uses thereof. | |
WO2022034524A3 (en) | Antibodies against ilt2 and use thereof | |
CR20220505A (en) | Anti-phf-tau antibodies and uses thereof | |
MX2023011339A (en) | Anti-tau antibodies and uses thereof. | |
ZA202110285B (en) | Antibodies and methods of use | |
MX2022013920A (en) | Anti-tumor associated antigen antibodies and uses thereof. | |
MX2023002948A (en) | Methods and compositions for modulating beta chain mediated immunity. | |
WO2021254574A3 (en) | Cd38 antibodies for the treatment of human diseases | |
SG148190A1 (en) | Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer | |
MX2022015966A (en) | Antibodies and methods for treating claudin-associated diseases. | |
WO2021067633A3 (en) | Kir3dl3 is an inhibitory receptor of the immune system and uses thereof | |
WO2024191972A3 (en) | Anti-lipocalin-2 antibodies and uses thereof | |
MX2022007513A (en) | Bispecific antibodies with alternatively matched interchain cycteines and uses thereof. | |
WO2023154626A3 (en) | Anti-il13ra2 antibodies and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24771571 Country of ref document: EP Kind code of ref document: A2 |